Appeals court greenlights stem-cell research

NewsGuard 100/100 Score

The court handed the Obama administration a victory by ruling that federal funding of human embryonic stem cell research can go forward.

National Journal: Appeals Court Hands Obama A Stem-Cell Victory
A U.S. appeals court handed the Obama administration a victory on Friday over the controversial issue of human embryonic stem cells, ruling that federal funding of such research may go ahead. The U.S Court of Appeals for the District of Columbia Circuit ruled 2-1 to overturn an earlier court ruling that stopped the National Institutes of Health from funding the research. This appeals case does not settle the matter — it merely allows the NIH to continue with the work while the main case goes through the courts. NIH has been doing so anyway, since the same appeals court made a tentative ruling last September (Fox, 4/29).

Politico: Appeals Court Overturns Ban On Stem Cell Research Funds
In a 2-1 decision, the appeals court ruled that "the plaintiffs are unlikely to prevail because Dickey-Wicker is ambiguous and the NIH seems reasonably to have concluded that although Dickey-Wicker bars funding for the destructive act of deriving an ESC from an embryo, it does not prohibit funding a research project in which an ESC will be used." The ruling is a win for the Obama administration, which has expanded the funding for stem cell research (Nocera, 4/29).

Bloomberg: U.S. Human Embryonic Stem-Cell Research Can Continue, Appeals Court Says
U.S. funding of human embryonic stem-cell studies can continue while a lower court decides whether the government-backed research violates the law, a federal appeals court said (Schoenberg and Riley, 4/29).

Reuters: Court Backs Federal Embryonic Stem Cells Funds
The appeals court overturned a ruling by a federal judge who found that the U.S. National Institutes of Health (NIH) guidelines on such research violated the law because embryos were destroyed and it put other researchers working with adult stem cells at a disadvantage to win federal grants (Pelofsky, 4/29). 


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
DELiVR's virtual reality training speeds up cell detection in complex brain datasets